218 related articles for article (PubMed ID: 12228187)
21. Factors influencing midazolam hydroxylation activity in human liver microsomes.
He P; Court MH; Greenblatt DJ; von Moltke LL
Drug Metab Dispos; 2006 Jul; 34(7):1198-207. PubMed ID: 16638818
[TBL] [Abstract][Full Text] [Related]
22. Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue.
Kivistö KT; Bookjans G; Fromm MF; Griese EU; Münzel P; Kroemer HK
Br J Clin Pharmacol; 1996 Sep; 42(3):387-9. PubMed ID: 8877031
[TBL] [Abstract][Full Text] [Related]
23. Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.
Westlind A; Malmebo S; Johansson I; Otter C; Andersson TB; Ingelman-Sundberg M; Oscarson M
Biochem Biophys Res Commun; 2001 Mar; 281(5):1349-55. PubMed ID: 11243885
[TBL] [Abstract][Full Text] [Related]
24. Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosterone.
Kamdem LK; Meineke I; Koch I; Zanger UM; Brockmöller J; Wojnowski L
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):71-7. PubMed ID: 15232676
[TBL] [Abstract][Full Text] [Related]
25. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
Yang HY; Lee QP; Rettie AE; Juchau MR
Mol Pharmacol; 1994 Nov; 46(5):922-8. PubMed ID: 7969081
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
[TBL] [Abstract][Full Text] [Related]
27. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M
Clin Pharmacol Ther; 2005 Apr; 77(4):259-70. PubMed ID: 15903124
[TBL] [Abstract][Full Text] [Related]
28. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.
Fakhoury M; Litalien C; Medard Y; Cavé H; Ezzahir N; Peuchmaur M; Jacqz-Aigrain E
Drug Metab Dispos; 2005 Nov; 33(11):1603-7. PubMed ID: 16049125
[TBL] [Abstract][Full Text] [Related]
29. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
[TBL] [Abstract][Full Text] [Related]
30. Variability in Expression of CYP3A5 in Human Fetal Liver.
Vyhlidal CA; Pearce RE; Gaedigk R; Calamia JC; Shuster DL; Thummel KE; Leeder JS
Drug Metab Dispos; 2015 Aug; 43(8):1286-93. PubMed ID: 25979262
[TBL] [Abstract][Full Text] [Related]
31. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.
Kolwankar D; Vuppalanchi R; Ethell B; Jones DR; Wrighton SA; Hall SD; Chalasani N
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):388-93. PubMed ID: 17368239
[TBL] [Abstract][Full Text] [Related]
32. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Williams JA; Ring BJ; Cantrell VE; Jones DR; Eckstein J; Ruterbories K; Hamman MA; Hall SD; Wrighton SA
Drug Metab Dispos; 2002 Aug; 30(8):883-91. PubMed ID: 12124305
[TBL] [Abstract][Full Text] [Related]
33. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.
Gibson GG; Plant NJ; Swales KE; Ayrton A; El-Sankary W
Xenobiotica; 2002 Mar; 32(3):165-206. PubMed ID: 11958559
[TBL] [Abstract][Full Text] [Related]
34. Regulation of CYP3A genes in the human respiratory tract.
Raunio H; Hakkola J; Pelkonen O
Chem Biol Interact; 2005 Jan; 151(2):53-62. PubMed ID: 15698577
[TBL] [Abstract][Full Text] [Related]
35. CYP3A gene expression in human gut epithelium.
Kolars JC; Lown KS; Schmiedlin-Ren P; Ghosh M; Fang C; Wrighton SA; Merion RM; Watkins PB
Pharmacogenetics; 1994 Oct; 4(5):247-59. PubMed ID: 7894497
[TBL] [Abstract][Full Text] [Related]
36. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
Schuetz JD; Kauma S; Guzelian PS
J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
[TBL] [Abstract][Full Text] [Related]
37. Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle.
Sarkar MA; Vadlamuri V; Ghosh S; Glover DD
Drug Metab Dispos; 2003 Jan; 31(1):1-6. PubMed ID: 12485945
[TBL] [Abstract][Full Text] [Related]
38. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor.
Usui T; Saitoh Y; Komada F
Biol Pharm Bull; 2003 Apr; 26(4):510-7. PubMed ID: 12673034
[TBL] [Abstract][Full Text] [Related]
39. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450.
Domanski TL; Finta C; Halpert JR; Zaphiropoulos PG
Mol Pharmacol; 2001 Feb; 59(2):386-92. PubMed ID: 11160876
[TBL] [Abstract][Full Text] [Related]
40. Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans.
Paulussen A; Lavrijsen K; Bohets H; Hendrickx J; Verhasselt P; Luyten W; Konings F; Armstrong M
Pharmacogenetics; 2000 Jul; 10(5):415-24. PubMed ID: 10898111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]